We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Biosimilars Forum applauds President Biden's directions to the U.S. Department of Health and Human Services "to increase support for generic and biosimilar drugs, which provide low-cost options for patients" .